Artículos por temáticas

Writing the Future: Artificial Intelligence, Handwriting, and Early Biomarkers for Parkinson's Disease Diagnosis and Monitoring

Marano G, Rossi S, Marzo EM, Ronsisvalle A, Artuso L, Traversi G, Pallotti A, Bove F, Piano C, Bentivoglio AR, Sani G, Mazza M; Lazio DBS Study Group.

Biomedicines. 2025 Jul 18;13(7):1764. doi: 10.3390/biomedicines13071764.

Fluid biomarkers in atypical Parkinsonism: current state and future perspectives

Bougea A, Colosimo C, Falup-Pecurariu C, Palermo G, Degirmenci Y.

J Neural Transm (Vienna). 2025 Jul;132(7):921-941. doi: 10.1007/s00702-025-02930-2. Epub 2025 May 20.

Exosomes as Biomarkers and Therapeutic Agents in Neurodegenerative Diseases: Current Insights and Future Directions

Dehghani S, Ocakcı O, Hatipoglu PT, Özalp VC, Tevlek A.

Mol Neurobiol. 2025 Jul;62(7):9190-9215. doi: 10.1007/s12035-025-04825-5. Epub 2025 Mar 17.

Large-scale plasma proteomics uncovers preclinical molecular signatures of Parkinson's disease and overlap with other neurodegenerative disorders

Homann J, Smith AG, Morgan S, Frick EA, Liu F, Viallon V, Maurya R, Korologou-Linden R, Dobricic V, Ohlei O, Deecke L, Hajizadah F, Zhao Y, Artaud F, Smith-Byrne K, Kolijn PM, Huerta JM, Winter N, Gue

medRxiv [Preprint]. 2025 Jul 30:2025.07.30.25332433. doi: 10.1101/2025.07.30.25332433.

Comparative efficacy and safety of irreversible (rasagiline) and reversible (safinamide) monoamine oxidase inhibitors as add-on therapy for Parkinson's disease

Khalid MB, Shahzad F, Siddiqui MR, Abedin MZU, Hulou S, Shami B, Ahmed SI.

J Neurol. 2025 Jul 1;272(7):486. doi: 10.1007/s00415-025-13230-w.

Non-invasive brain stimulation to enhance sleep quality and architecture in Parkinson's disease: A systematic review and Bayesian network meta-analysis

Cristini J, Medina-Rincon A, Van Roy A, Seo F, Moncion K, Carrier J, Paquette C, Dagher A, Steib S, Roig M.

Sleep Med Rev. 2025 Aug;82:102117. doi: 10.1016/j.smrv.2025.102117. Epub 2025 Jun 19.

Understanding barriers and facilitators to participation in Parkinson's research in Black communities in the UK

Dobreva I, Kalam S, Roche M, Bayram E, Weil RS, Zarkali A.

J Parkinsons Dis. 2025 Aug;15(5):1035-1039. doi: 10.1177/1877718X251351990. Epub 2025 Jun 20.

Implications and opportunities regarding biological frameworks in overt and prodromal dementia with Lewy bodies

Goldman JG, Boeve BF, Galasko D, Taylor JP, Galvin JE, Leverenz JB, Blanc F, Halliday G, Kantarci K, Lemstra AW, Leroi I, Lewis SJG, Litvan I, Medsger H, O'Brien J, Scholz SW, Aarsland D, Ikeda M, McK

Alzheimers Dement. 2025 Jul;21(7):e70470. doi: 10.1002/alz.70470.

A Systematic Review of the Parkinson's Foundation Hospital Care Recommendations

Veilleux Carpentier A, Malaty IA, LeWitt PA, Azmi H, Brooks A, Pollak E, Air EL, Simpson H, Thomas J, Thomas FP, Cocoziello L, Rosenfeld S, Okun MS.

Mov Disord Clin Pract. 2025 Jul 30. doi: 10.1002/mdc3.70247. Online ahead of print.

Characteristics and Validity of Commercially Available Technologies Analyzing Voice Features to Assess Parkinson's Disease

Dean JM, Iankova V, Roberts A, Schneider SA.

Mov Disord Clin Pract. 2025 Jul 11. doi: 10.1002/mdc3.70214. Online ahead of print.

Potential Roles of Natural Antioxidants in Modulating Neurodegenerative Disease Pathways

Oyovwi MO, Chijiokwu EA, Ben-Azu B, Atere AD, Joseph UG, Ogbutor UG, Udi OA.

Mol Neurobiol. 2025 Aug;62(8):10367-10397. doi: 10.1007/s12035-025-04874-w. Epub 2025 Apr 9.

Intraputaminal Delivery of Adeno-Associated Virus Serotype 2-Glial Cell Line-Derived Neurotrophic Factor in Mild or Moderate Parkinson's Disease

Van Laar AD, Christine CW, Phielipp N, Larson PS, Elder JB, Merola A, San Sebastian W, Fiandaca MS, Kells AP, Wisniewski ME, Bankiewicz KS.

Mov Disord. 2025 Jul;40(7):1297-1306. doi: 10.1002/mds.30193. Epub 2025 May 20.

Influence of wearable rhythmic auditory stimulation on Parkinson's disease, multiple sclerosis, and stroke: a systematic review and meta-analysis

Scataglini S, Van Bocxlaer C, Jansen L, Van Es L, Van Laerhoven C, Truijen S.

Sci Rep. 2025 Jul 1;15(1):21432. doi: 10.1038/s41598-025-05952-8.

Parkinson's disease: exploring the systemic immune mechanisms through molecular investigations

Mohan M, Mannan A, Singh TG.

Inflammopharmacology. 2025 Jul;33(7):3679-3699. doi: 10.1007/s10787-025-01816-9. Epub 2025 Jun 23.

Development and Preliminary Validation of a Parkinsonism-Dystonia Scale for Infants and Young Children

Pons R, Pearson TS, Perez-Dueñas B, Garcia-Cazorla A, Kurian MA, Dalivigka Z, Zouvelou V, Outsika C, Kokkinou E, Sigatullina-Bondarenko M, Darling A, O'Callaghan MDM, Spaull R, Steel DBD, Salamou E, F

Mov Disord. 2025 Aug;40(8):1669-1679. doi: 10.1002/mds.30219. Epub 2025 May 13.